Best Society For Post Acute Podcasts (2024)

1
Mutational and transcriptional landscape of pediatric BCP lymphoblastic lymphoma; the role of platelet-derived TGF-1 in immune thrombocytopenia; phase 3 trial of mavorixafor in WHIM syndrome 23:25

1h ago23:25

23:25

In this week's episode we’ll discuss the mutational and transcriptional landscape of pediatric BCP lymphoblastic leukemia; learn more about the role of platelet-derived TGF-β1 in immune thrombocytopenia; and discuss the findings from a phase 3 trial of mavorixafor in WHIM syndrome. Featured Articles: Mutational and transcriptional landscape of pedi…

1
AMDA On-The-Go | The Empowering Three-Part Series | Speaking and Listening in Ways That Matter (Part 2 of 3) 36:31

3d ago36:31

36:31

Episode: The Empowering Three-Part Series | Speaking and Listening in Ways That Matter (Part 2 of 3) Host: Diane Sanders-Cepeda, DO, CMD Guest(s): Aya Caspi In This Episode: In this episode, host Diane Sanders-Cepeda, DO, CMD, and special guest Aya Caspi, discuss how to speak and listen in a way that lets others know they matter without having to a…

1
GM-CSF coordinates shelter in the cytokine storm; Interleukin-1 as a therapeutic target in TTP; CAR T-cell outcomes across race and ethnicity in LBCL 19:57

7d ago19:57

19:57

In this week's episode we'll discuss new insights on the role of GM-CSF in establishing immune memory. The authors propose that the coordination of opposing immune memory programs, driven by GM-CSF, may be essential to efficient, yet controlled, innate immune responses. After that: Interleukin-1 inhibition in TTP. Researchers explore the potential …

1
Review Series on Oncogenic Signaling and Immune Evasion in Hematologic Malignancies 15:41

7d ago15:41

15:41

Introduced by Associate Editor Robert Zeiser, this Review Series focuses on the problem of immune escape by acute myeloid leukemia (AML). The series opens with a review of how AML escapes T-cell–driven elimination and then focuses on how p53 function impinges on AML recognition by immune cells. The series finishes with a summary of new approaches t…

1
JAMDA On-The-Go | June 2024 30:49

13d ago30:49

30:49

Episode: June 2024 Host: Karl Steinberg, MD, HMDC, CMD Guest(s): Tess Jones, PhD, LMSW; Barbara Resnick, PhD, CRNP (co-editor-in-chief) In This Episode: In this episode, host Dr. Karl Steinberg, MD, CMD, and co-editor-in-chief Dr. Barb Resnick, PhD, CRNP, will talk with Tessa Jones, PhD, LMSW, about her work entitled, Race and Ethnicity Are Related…

1
Reassessing the CLL prognostic index; ADAMTS13 conformation and risk of relapse in immune-mediated TTP; haploidentical bone marrow transplant in sickle cell disease 23:39

14d ago23:39

23:39

In this week's episode we’ll discuss the prognostic value of the Chronic Lymphocytic Leukemia International Prognostic Index in the era of targeted therapies, learn how peak ADAMTS13 activity can be used to assess ADAMTS13 conformation and risk of relapse in immune-mediated thrombotic thrombocytopenic purpura, and discuss the findings from a phase …

1
AMDA On-The-Go | The Empowering Three-Part Series | Building Trust (Part 1 of 3) 33:20

17d ago33:20

33:20

Episode: The Empowering Three-Part Series | Building Trust (Part 1 of 3) Host: Diane Sanders-Cepeda, DO, CMD Guest(s): Aya Caspi In This Episode: In this episode, host Diane Sanders-Cepeda, DO, CMD, and special guest Aya Caspi, discuss what to do and say to show care and restore trust when our choices of words and actions have a negative impact on …

1
A biomarker for disease severity in Wiskott-Aldrich Syndrome; loss of Dnmt3a confers resistance to IFNα; unrelated donor selection in HSCT with PTCy 19:16

21d ago19:16

19:16

In this week's episode we'll discuss assessing risk profile in Wiskott-Aldrich Syndrome, or WAS. Then, we'll learn about how the loss of DNMT3A confers resistance to interferon-alpha in hematopoietic stem cells carrying the JAK2-V617F mutation. Finally, we'll explore unrelated donor selection for AML patients undergoing hematopoietic stem cell tran…

1
Nilotinib with or without cytarabine for Philadelphia-positive AML; thrombosis risk in Factor V Leiden and Prothrombin G20210A; ctDNA improves prognostic prediction in relapsed/refractory multiple myeloma ... 23:05

28d ago23:05

23:05

In this week's episode we’ll discuss the safety and efficacy of nilotinib with or without cytarabine in Philadelphia-positive acute lymphoblastic leukemia; learn more about thrombosis risk in double heterozygous carriers of Factor V Leiden and prothrombin G20210A and discuss the utility of circulating cell-free tumor DNA in prognostic prediction in…

1
JAMDA On-The-Go | May 2024 28:58

1M ago28:58

28:58

Episode: May 2024 Host: Karl Steinberg, MD, HMDC, CMD Guest(s): Geoffrey Gusoff, MD, MBA, MS; Stina Ek, PhD; Paul Katz, MD, CMD (co-editor-in-chief) In This Episode: In this episode, host Karl Steinberg, MD, CMD, and co-editor-in-chief Paul Katz, MD, CMD, will discuss three articles from the May issue. First, they will talk with first author Geoffr…

1
Hemophilia prophylaxis with fitusiran vs BPA/CFC; germline NBN variants in pediatric B-ALL; Histone demethylation and cell-intrinsic immune response in AML 18:59

1M ago18:59

18:59

In this week's episode we'll learn about fitusiran prophylaxis in patients with hemophilia A or B, with or without inhibitors. Next we'll hear about new findings that heterozygous germline variants in the NBN gene that are linked to increased risk of B-cell acute lymphoblastic leukemia in children. Finally, we'll explore new insights on the histone…

1
Effects of voxelotor on cerebral blood flow in pediatric sickle cell disease; thrombosis in Vexas syndrome; response to tyrosine kinase inhibitors in ABL-class acute lymphoblastic leukemia 22:26

1M ago22:26

22:26

In this week's episode we’ll discuss the effects of voxelotor on cerebral blood flow in pediatric sickle cell disease, learn more about venous and arterial thrombosis in patients with Vexas syndrome, and discuss differential sensitivity to tyrosine kinase inhibitors in ABL-class acute lymphoblastic leukemia. Featured Articles: The influence of voxe…

1
Stamping out high-risk myeloma with D-KRd and tandem transplant; plasmin-cleaved VWF in microthrombosis; SCD plasma sensitizes iPSC-derived sensory neurons 19:40

2M ago19:40

19:40

In this week's podcast we'll discuss another step forward in stamping out high-risk myeloma. Then we'll hear about the plasmin-cleaved von Willebrand factor, or VWF, in microthrombosis. Finally we'll hear about new insights into the origins of sickle cell pain. Featured Articles: Daratumumab, carfilzomib, lenalidomide, and dexamethasone with tandem…

1
AMDA On-The-Go | D2D Edition | Deprescribing of Anticoagulants: The IF, WHEN and HOW, a Discussion with a Cardiologist 35:41

2M ago35:41

35:41

Episode: D2D Edition | Deprescribing of Anticoagulants: The IF, WHEN and HOW, a Discussion with a Cardiologist Host: Sabine von Preyss-Friedman MD, FACP, CMD Guest(s): Nicole Orr, MD; Irene Hamrick MD, CMD In This Episode: In this episode, host Sabine von Preyss-Friedman, MD, FACP, CMD, and special guests Nicole Orr, MD, and Irene Hamrick, MD, CMD,…

1
Caring On-The-Go | May 2024: Heart Disease and Matters of the Heart, With Special Guest Dr. Nicole Orr 34:25

2M ago34:25

34:25

Episode: May 2024 Host: Karl Steinberg, MD, HMDC, CMD Guest(s): Elizabeth Galik, PhD, CRNP (editor-in-chief); Nicole Orr, MD In This Episode: In this episode, host Dr. Karl Steinberg, MD, CMD, and editor-in-chief Dr. Elizabeth Galik, PhD, CRNP, discuss our May issue of Caring for the Ages with guest Nicole Orr, MD. This issue contains and special s…

1
Allogeneic transplant in first remission for post-induction molecular MRD; circulating HSPCs actively participate in human hematopoiesis; let-7 miRNAs repress HIC2 to regulate BCL11A transcription and ... 21:44

2M ago21:44

21:44

In this week's episode we’ll discuss the utility of MRD in identifying patients with NPM1 AML who benefit from allogeneic transplant in first remission, learn more about the contribution of circulating hematopoietic stem/progenitor cell subsets to human hematopoietic hemostasis, and discuss the role of Let-7 miRNAs in regulation of BCL11A transcrip…

1
ADAMTS13 recovery in caplacizumab-treated TTP; inhibition of venetoclax-resistant BCL2 variants with sonrotoclax; genomic insights from Castleman disease in twins 19:10

2M ago19:10

19:10

In this week's epside we'll learn about ADAMTS recovery after caplacizumab therapy in patients with immune thrombotic thrombocytopenic purpura. Then, we'll hear about preclinical characterization of sonrotoclax, a potential second-generation BCL2 inhibitor. Finally we'll hear about new insights into the etiology of Castleman disease where researche…

1
Durable response after tisa-cel in adults with relapsed/refractory follicular lymphoma; high microRNA-145 plasma levels indicate decreased risk of VTE; epigenetic/immunogenetic signature in the prediction ... 23:49

2M ago23:49

23:49

In this week's episode, we’ll discuss the findings from a study assessing responses after treatment with tisagenlecleucel [LM1] in adults with relapsed/refractory follicular lymphoma, learn more about the association between high microRNA-145 plasma levels and decreased risk of future incident venous thromboembolism, and discuss how epigenetic and …

1
Gut microbiota exploitation by CPX-351 in AML; optimizing anti-myeloma immunity for ASCT; which pediatric ITP patients will develop lupus? 19:00

3M ago19:00

19:00

In this week's episode, we'll discuss gut microbiota exploitation by CPX-351 in acute myeloid leukemia. Then we'll learn about optimizing anti-myeloma immunity. New research shows that regulatory T cells suppress myeloma-specific immunity during autologous stem cell mobilization and transplantation. Finally we'll discuss among pediatric patients wi…

1
AMDA On-The-Go | Assisted Living Three-Part Series | Palliative Care and Goals of Care in AL (Part 3 of 3) 46:02

3M ago46:02

46:02

Episode: Assisted Living Three-Part Series | Palliative Care and Goals of Care in AL (Part 3 of 3) Host: Diane Sanders-Cepeda, DO, CMD Guest(s): Michael Nash, MD, CMD; Katie O’Brien, MD, CMD In This Episode: In this episode, host Diane Sanders-Cepeda, DO, CMD, and special guests Michael Nash, MD, CMD, and Katie O’Brien, MD, CMD, discuss framing goa…

1
JAMDA On-The-Go | April 2024 43:44

3M ago43:44

43:44

Episode: April 2024 Host: Karl Steinberg, MD, HMDC, CMD Guest(s): E-Shien (Iggy) Chang, PhD; Barbara Resnick, PhD, CRNP (co-editor-in-chief) In This Episode: In this episode, host Dr. Karl Steinberg, MD, CMD, and co-editor-in-chief Dr. Barb Resnick, PhD, CRNP, will talk with Dr. E-Shien (Iggy) Chang, PhD, about her work exploring overt racial and e…

1
Jak2V617F clonal hematopoiesis promotes arterial thrombosis; Staphylococcus aureus infection in Sézary syndrome; clinical features of RAC2-related immunodeficiency 26:18

3M ago26:18

26:18

In this week's episode we’ll discuss the mechanism by which Jak2V617F clonal hematopoiesis promotes arterial thrombosis, discuss how Staphylococcus aureus induces drug resistance in cancer T cells in Sézary syndrome, and learn more about the clinical and functional features of RAC2-related immunodeficiency. Featured Articles: Jak2V617F clonal hemat…

1
AMDA On-The-Hill | March 2024 7:43

3M ago7:43

7:43

Episode: March 2024 Alex Bardakh, MPP, CAE, the Society’s Senior Director of Advocacy and Strategic Partnerships, shares the latest news from the nation’s capital. Questions? Email Alex at abardakh@paltc.org. No credit is available for this program.By Society for Post-Acute and Long-Term Care Medicine

1
Caring On-The-Go | April 2024: With Special Guests Glenn Tillotson on Clostridioides Difficile and Allison Villegas on Advanced Practice Providers 35:19

3M ago35:19

35:19

Episode: April 2024 Host: Karl Steinberg, MD, HMDC, CMD Guest(s): Elizabeth Galik, PhD, CRNP (editor-in-chief); Glenn Tillotson; Allison Villegas, PA-C In This Episode: In this episode, host Dr. Karl Steinberg, MD, CMD, and editor-in-chief Dr. Elizabeth Galik, PhD, CRNP, discuss our April issue of Caring for the Ages with special guests Glenn Tillo…

1
AMDA On-The-Go | Update on RSV Vaccines 31:44

3M ago31:44

31:44

Episode: RSV Vaccinations in PALTC Host: Diane Sanders-Cepeda, DO, CMD Guest(s): Ann R. Falsey, MD In This Episode: In this episode, host Diane Sanders-Cepeda, DO, CMD, and special guest Ann R. Falsey, MD, will discuss respiratory syncytial virus (RSV) vaccines, the current RSV Advisory Committee on Immunization Practices (ACIP) recommendations, an…

1
Molecular mimicry in aplastic anemia; emicizumab prophylaxis in infants with hemophilia; hydroxyurea reduces infections in SCA 19:54

3M ago19:54

19:54

In this week's episode we'll discuss molecular mimicry in aplastic anemia, novel experiments show that antigens associated with viral infections can mimic epitopes presented on hematopoietic progenitor cells. Then, we'll learn about prophylaxis with subcutaneous emicizumab in infants with hemophilia. Finally we'll see how hydroxyurea is associated …

1
Review Series on the Influence of the Tumor Microenvironment on the Pathogenesis of B-Cell Lymphomas 32:05

3M ago32:05

32:05

In this bonus episode of Blood Podcast, Associate Editor, Dr. Freda Stevenson is joined by Drs. Karin Tarte, Andrea Radtke, and Leandro Cerchietti to discuss the Review Series on the influence of the tumor microenvironment on the pathogenesis of B-cell lymphomas. Find the full review series in Blood Journal volume 143 issue 12.…

1
Free light chain mass spectrometry in diagnosis and monitoring of AL amyloidosis; T cells of AML patients in remission have distinct RNA signatures; and protective effect of ADAMTS13 in sickle cell mice ... 22:34

3M ago22:34

22:34

In this week's episode we’ll discuss the findings from a study assessing the utility of free light chain mass spectrometry in AL amyloidosis, learn more about distinct single-cell RNA-sequencing signatures of bone marrow T cells of AML patients in remission after an allogeneic stem cell transplant, and discuss why von Willebrand factor clearance is…

1
JAMDA On-The-Go | March 2024 36:11

3M ago36:11

36:11

Episode: March 2024 Host: Karl Steinberg, MD, HMDC, CMD Guest(s): Emily Morgan, MD; Jessica Rice Williams, PhD; Barbara Resnick, PhD, CRNP (co-editor-in-chief); Paul Katz, MD, CMD (co-editor-in-chief) In This Episode: In this episode, host Dr. Karl Steinberg, MD, HMDC, CMD, and co-editors-in-chief Barbara Resnick, PhD, CRNP, and Paul Katz, MD, CMD,…

1
Eculizumab in transplant-associated thrombotic microangiopathy; reclassifying malignant monocytosis; targeting tissue factor in antiphospholipid syndrome 20:50

3M ago20:50

20:50

In this week's episode we'll discuss eculizumab in stem cell transplant-associated thrombotic microangiopathy. Then, we'll learn about reclassifying malignant monocytosis, these newly classified cases have distinct mutational and transcriptional profiles. Finally, we'll hear about targeting the tissue factor coagulation initiation complex prevents …

1
AMDA On-The-Go | Assisted Living Three-Part Series | Transitions of Care and Challenges in AL (Part 2 of 3) 44:59

4M ago44:59

44:59

Episode: Assisted Living Three-Part Series | Transitions of Care and Challenges in AL (Part 2 of 3) Host: Diane Sanders-Cepeda, DO, CMD Guest(s): Michael Nash, MD, CMD; Katie O’Brien, MD, CMD; Sing Palat, MD, CMD In This Episode: In this episode, host Diane Sanders-Cepeda, DO, CMD, and special guests Michael Nash, MD, CMD, Katie O’Brien, MD, CMD, a…

1
Identification of rare relapse-initiating stem cells post-transplantation; interferon α impairs erythropoiesis in sickle cell disease; TNFα promotes clonal dominance of KIT D816V+ cells in mastocytosis ... 22:48

4M ago22:48

22:48

In this week's episode we’ll learn more about rare relapse-initiating stem cells in patients with MDS or AML in complete remission post-transplantation, discuss the role of interferon α in erythropoiesis in sickle cell disease, and learn more about how TNFα promotes clonal dominance of KIT D816V+ cells in mastocytosis.…

1
Caring On-The-Go | March 2024 32:29

4M ago32:29

32:29

Episode: March 2024 Host: Karl Steinberg, MD, HMDC, CMD Guest(s): Elizabeth Galik, PhD, CRNP (editor-in-chief) In This Episode: In this episode, host Dr. Karl Steinberg, MD, CMD, editor-in-chief Dr. Elizabeth Galik, PhD, CRNP, discuss our March issue of Caring for the Ages. This month, our cover features the last editorial from long-time member of …

1
How PAR2 signaling drives thrombo-inflammation; pretransfusion hemoglobin levels linked to survival in beta-thalassemia; etoposide is better than its reputation in primary HLH 17:48

4M ago17:48

17:48

In this week's episode we'll discuss PAR2-biased signaling in thrombo-inflammation. Then, we'll learn about how hemoglobin levels are linked to survival in transfusion-dependent beta-thalassemia. Finally we'll hear about how etoposide is better than its reputation in primary HLH—hemophagocytic lymphohistiocytosis. Symptomatic patients treated with …

1
Antimicrobial Stewardship & Quality 55:40

4M ago55:40

55:40

Join special guest, Dr. Swati Gaur, and your host, Dr. Diane Sanders-Cepeda, for this special episode of FMDA’s Journal Club, Antimicrobial Stewardship & Quality. This session focused on the following Learning Objectives: Revisit current guidance and protocols for Antimicrobial Stewardship in our PALTC facilities. Discuss how we are tackling vaccin…

1
Episode 2: The nuances of pertussis infection in adults with chronic medical conditions 18:42

4M ago18:42

18:42

Certain adult populations are at increased risk of severe disease from pertussis; however, which adults are more susceptible to severe pertussis disease, and how does pertussis affect these adults? Host, Liana Clark, meets with leading experts in the field to explore the affect of pertussis on adults with existing chronic medical conditions and str…

1
Episode 1: Exploring pertussis infection in all adults 23:53

4M ago23:53

23:53

Pertussis is a highly contagious bacterial infection that is widely considered to be a disease of childhood – but what is the impact of pertussis in the adult population? Host, Liana Clark, meets with leading experts in the field to delve deeper into the impact of pertussis infection in adults and explore how vaccination can protect them against th…

1
Brentuximab vedotin plus dacarbazine or nivolumab in classical Hodgkin lymphoma; loss of CD20 causes resistance to mosunetuzumab in r/r B-cell lymphomas; trogocytosis as a driver of RBC antigen loss 23:02

4M ago23:02

23:02

In this week's episode we’ll discuss the findings from a prospective trial of brentuximab vedotin with dacarbazine or nivolumab in older patients with classical Hodgkin lymphoma, learn more about CD20 antigen loss as a mechanism of resistance to mosunetuzumab in relapsed/refractory B-cell lymphomas, and discuss the role of trogocytosis in red blood…

1
AMDA On-The-Go | Assisted Living Three-Part Series | Current Landscape of AL (Part 1 of 3) 37:36

4M ago37:36

37:36

Episode: Assisted Living Three-Part Series | Current Landscape of AL (Part 1 of 3) Host: Diane Sanders-Cepeda, DO, CMD Guest(s): Michael Nash, MD, CMD; Katie O’Brien, MD, CMD In This Episode: In this episode, host Diane Sanders-Cepeda, DO, CMD, and special guests Michael Nash, MD, CMD, and Katie O’Brien, MD, CMD, discuss the current state of assist…

1
CAR T cells plus ibrutinib in relapsed/refractory MCL; targeting SGF29 in AML; diffusion-limited oxygen release from stored blood 18:50

4M ago18:50

18:50

In this week's episode we'll discuss CAR T cells plus ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma. Next, we'll learn about a new SAGA for acute myeloid leukemia. Finally, we'll hear about new evidence that oxygen delivery to tissues can become diffusion-limited during perfusion with stored blood.…

1
JAMDA On-The-Go | February 2024 36:08

5M ago36:08

36:08

Episode: February 2024 Host: Karl Steinberg, MD, HMDC, CMD Guest(s): Victoria Shier, PhD, MPA; Barbara Resnick, PhD, CRNP (co-editor-in-chief) In This Episode: In this episode, host Karl Steinberg, MD, CMD, and co-editor-in-chief Barbara Resnick, PhD, CRNP, will talk with Victoria Shier, PhD, MPA, about her work on the association between state dem…

1
Long-term outcomes of pulmonary embolism in children and adolescents; hereditary angioedema caused by a methionine-379 to lysine substitution in kininogens; predictors of loss of MRD negativity in multiple ... 25:07

5M ago25:07

25:07

In this week's episode we’ll report on the findings from a study evaluating the long-term outcomes of pulmonary embolism in children and adolescents, discuss a new mechanism for hereditary angioedema caused by a methionine-379 to lysine substitution in kininogens, and learn more about predictors of unsustained minimal residual disease negativity in…

1
Extended follow-up of axi-cel in indolent NHL; platelets help clear senescent RBCs; novel risk stratification strategy for CNS lymphoma 18:58

5M ago18:58

18:58

In this week's episode we'll discuss extended follow-up from the ZUMA-5 trial of axicabtagene ciloleucel, or axi-cel. Then we'll learn about the role of platelets in binding and clearing senescent red blood cells. Finally, we'll hear about a new risk stratification strategy for lymphomas of the central nervous system, or CNS.…

1
AMDA On-The-Go | Ageism Two-Part Series | Is Ageism the Cornerstone of Our PALTC Infrastructure? (Part 2 of 2) 34:42

5M ago34:42

34:42

Episode: Ageism Two-Part Series | Is Ageism the Cornerstone of our PALTC Infrastructure? (Part 2 of 2) Host: Diane Sanders-Cepeda, DO, CMD Guest(s): Cynthia Kuttner, MD, CMD; Fatima Naqvi, MD, CMD In This Episode: In this episode, host Diane Sanders-Cepeda, DO, CMD, and special guests Cynthia Kuttner, MD, CMD, and Fatima Naqvi, MD, CMD discuss our …

1
Lisocabtagene maraleucel in relapsed or refractory large B-cell lymphoma; reciprocal stabilization of coagulation factor XIII-A and -B subunits; inotuzumab ozogamicin for MRD in ALL 22:26

5M ago22:26

22:26

In this week's episode we’ll discuss the findings from a two-year follow-up study of lisocabtagene maraleucel in relapsed or refractory large B-cell lymphoma, learn more about how reciprocal stabilization of coagulation factor XIII-A and -B subunits influences plasma FXIII concentration, and discuss the findings from a phase 2 study of inotuzumab o…

1
JAMDA On-The-Go | January 2024 38:18

5M ago38:18

38:18

Episode: January 2024 Host: Karl Steinberg, MD, HMDC, CMD Guest(s): Gregory L. Alexander, PhD, RN; Micah Segelman, PhD; Paul Katz, MD, CMD (co-editor-in-chief) In This Episode: In this episode, host Karl Steinberg, MD, CMD, and co-editor-in-chief Paul Katz, MD, CMD, will talk with two authors, Gregory L. Alexander, PhD, RN and Micah Segelman, PhD, …

1
Maternal anticancer drug exposure and leukemia; PIEZO1-TMEM16F coupling in hereditary xerocytosis; NPM1 MRD during venetoclax therapy in NPM1-mutated AML 18:12

5M ago18:12

18:12

In this week’s episode, we’ll discuss the association between occupational exposure to anticancer agents in a parent and subsequent cancer in a child. Then we’ll learn about deciphering and disrupting the activation of PIEZO1 in hereditary xerocytosis. Finally, we’ll hear about the assessment of measurable residual disease, or MRD, in patients with…

1
AMDA On-The-Go | Ageism Two-Part Series | The Culture of Aging and the Bias of Ageism (Part 1 of 2) 36:53

6M ago36:53

36:53

Episode: Ageism Two-Part Series | The Culture of Aging and the Bias of Ageism (Part 1 of 2) Host: Diane Sanders-Cepeda, DO, CMD Guest(s): Cynthia Kuttner, MD, CMD; Fatima Naqvi, MD, CMD In This Episode: In this episode, host Diane Sanders-Cepeda, DO, CMD, and special guests Cynthia Kuttner, MD, CMD, and Fatima Naqvi, MD, CMD discuss our attitudes t…

1
TCRαβ/CD19-cell depleted haploHSCT for pediatric leukemia; malignancy-associated hemophagocytic lymphohistiocytosis in Sweden; the bone marrow as the primary site of thrombopoiesis 21:55

6M ago21:55

21:55

In this week's episode we’ll discuss the findings from a prospective trial of TCRαβ/CD19-cell depleted HLA-haploidentical transplantation to treat pediatric acute leukemia, learn more about the incidence, clinical characteristics, and survival of malignancy-associated hemophagocytic lymphohistiocytosis in Sweden, and discuss the bone marrow as the …

1
AMDA On-The-Go | BPSD Bootcamp: What to Do in a Crisis? (Part 2 of 2) 37:43

6M ago37:43

37:43

Episode: BPSD Bootcamp: What to Do in a Crisis? (Part 2 of 2) Host: Diane Sanders-Cepeda, DO, CMD Guest(s): Tana Whitt, MSN, PMHNP-BC; Charissa Duffy, DNP, MSN, APRN, PMHNP-BC; Anthony Nedelman, PhD In This Episode: In this episode, host Diane Sanders-Cepeda, DO, CMD, and special guests Tana Whitt, MSN, PMHNP-MC; Charissa Duffy DNP, MSN, APRN, PMHN…

Podcasts Worth a Listen

Society For Post Acute Podcasts

Podcasts Worth a Listen

Quick Reference Guide